Insider · CIK 0001836430

Chopas James George

Reports to the SEC for 2 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001836430

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-14	APLSApellis Pharmaceuticals, Inc.U Disposition from Tender	VP/Chief Accounting Officer	UDisposition from Tender	−66K sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc. · Stock Option (right to buy)D Disposition to Issuer	VP/Chief Accounting Officer	DDisposition to Issuer	−21.8K sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc. · Stock Option (right to buy)D Disposition to Issuer	VP/Chief Accounting Officer	DDisposition to Issuer	−12.1K sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc. · Stock Option (right to buy)D Disposition to Issuer	VP/Chief Accounting Officer	DDisposition to Issuer	−15.1K sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc. · Stock Option (right to buy)D Disposition to Issuer	VP/Chief Accounting Officer	DDisposition to Issuer	−20.9K sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc. · Stock Option (right to buy)D Disposition to Issuer	VP/Chief Accounting Officer	DDisposition to Issuer	−11.3K sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc.D Disposition to Issuer	VP/Chief Accounting Officer	DDisposition to Issuer	−6,250 sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc.D Disposition to Issuer	VP/Chief Accounting Officer	DDisposition to Issuer	−16.2K sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc.D Disposition to Issuer	VP/Chief Accounting Officer	DDisposition to Issuer	−9,444 sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc.D Disposition to Issuer	VP/Chief Accounting Officer	DDisposition to Issuer	−4,156 sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc.D Disposition to Issuer	VP/Chief Accounting Officer	DDisposition to Issuer	−2,406 sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc.D Disposition to Issuer	VP/Chief Accounting Officer	DDisposition to Issuer	−8,075 sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc.A Award	VP/Chief Accounting Officer	AAward	+8,075 sh	—	—	8,075
2026-05-14	APLSApellis Pharmaceuticals, Inc.D Disposition to Issuer	VP/Chief Accounting Officer	DDisposition to Issuer	−16.2K sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc.A Award	VP/Chief Accounting Officer	AAward	+16.2K sh	—	—	16,150
2026-05-14	APLSApellis Pharmaceuticals, Inc.D Disposition to Issuer	VP/Chief Accounting Officer	DDisposition to Issuer	−8,394 sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc.A Award	VP/Chief Accounting Officer	AAward	+8,394 sh	—	—	8,394
2026-05-14	APLSApellis Pharmaceuticals, Inc.D Disposition to Issuer	VP/Chief Accounting Officer	DDisposition to Issuer	−5,625 sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc.A Award	VP/Chief Accounting Officer	AAward	+5,625 sh	—	—	5,625
2026-01-28	APLSApellis Pharmaceuticals, Inc.A Award	VP/Chief Accounting Officer	AAward	+16.2K sh	—	—	65,955
2026-01-22	APLSApellis Pharmaceuticals, Inc.S Sale	VP/Chief Accounting Officer	SSale	−2,064 sh	$21.77	−$44.9K	49,805
2026-01-20	APLSApellis Pharmaceuticals, Inc.S Sale	VP/Chief Accounting Officer	SSale	−726 sh	$19.79	−$14.4K	51,869
2026-01-13	APLSApellis Pharmaceuticals, Inc.S Sale	VP/Chief Accounting Officer	SSale	−873 sh	$22.19	−$19.4K	52,595
2025-09-15	APLSApellis Pharmaceuticals, Inc.S Sale	VP/Chief Accounting Officer	SSale	−189 sh	$24.19	−$4,572.288	53,468
2025-09-02	APLSApellis Pharmaceuticals, Inc.S Sale	VP/Chief Accounting Officer	SSale	−548 sh	$28.08	−$15.4K	53,657
2025-06-18	APLSApellis Pharmaceuticals, Inc.A Award	VP/Chief Accounting Officer	AAward	+6,250 sh	—	—	54,205
2025-06-09	APLSApellis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	VP/Chief Accounting Officer	AAward	+11.3K sh	$19.39	+$218K	11,250
2025-03-17	APLSApellis Pharmaceuticals, Inc.S Sale	VP/Chief Accounting Officer	SSale	−183 sh	$24.82	−$4,542.737	47,955
2025-01-22	APLSApellis Pharmaceuticals, Inc.S Sale	VP/Chief Accounting Officer	SSale	−1,096 sh	$30.43	−$33.3K	48,138
2025-01-21	APLSApellis Pharmaceuticals, Inc.A Award	VP/Chief Accounting Officer	AAward	+12.6K sh	—	—	49,234
2025-01-17	APLSApellis Pharmaceuticals, Inc.S Sale	VP/Chief Accounting Officer	SSale	−715 sh	$29.96	−$21.4K	36,643
2025-01-13	APLSApellis Pharmaceuticals, Inc.S Sale	VP/Chief Accounting Officer	SSale	−783 sh	$28.70	−$22.5K	37,358
2024-09-16	APLSApellis Pharmaceuticals, Inc.S Sale	VP/Chief Accounting Officer	SSale	−192 sh	$36.21	−$6,951.552	38,141
2024-09-03	APLSApellis Pharmaceuticals, Inc.S Sale	VP/Chief Accounting Officer	SSale	−550 sh	$39.49	−$21.7K	38,333
2024-03-15	APLSApellis Pharmaceuticals, Inc.S Sale	VP/Chief Accounting Officer	SSale	−184 sh	$56.46	−$10.4K	38,883
2024-01-22	APLSApellis Pharmaceuticals, Inc.S Sale	VP/Chief Accounting Officer	SSale	−1,061 sh	$65.00	−$69K	39,067
2024-01-16	APLSApellis Pharmaceuticals, Inc.A Award	VP/Chief Accounting Officer	AAward	+8,312 sh	—	—	40,992
2024-01-16	APLSApellis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	VP/Chief Accounting Officer	AAward	+12.1K sh	$66.30	+$801K	12,086
2024-01-16	APLSApellis Pharmaceuticals, Inc.S Sale	VP/Chief Accounting Officer	SSale	−864 sh	$66.81	−$57.7K	40,128
2023-10-23	APLSApellis Pharmaceuticals, Inc.S Sale	VP/Chief Accounting Officer	SSale	−132 sh	$46.04	−$6,076.778	32,680
2023-09-14	APLSApellis Pharmaceuticals, Inc.A Award	VP/Chief Accounting Officer	AAward	+2,500 sh	—	—	32,812
2023-08-31	APLSApellis Pharmaceuticals, Inc.S Sale	VP/Chief Accounting Officer	SSale	−551 sh	$41.23	−$22.7K	30,312
2023-02-21	APLSApellis Pharmaceuticals, Inc.F Tax Payment	VP/Chief Accounting Officer	FTax Payment	−334 sh	$58.50	−$19.5K	30,863
2023-02-21	APLSApellis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	VP/Chief Accounting Officer	AAward	+5,737 sh	—	—	5,737
2023-02-21	APLSApellis Pharmaceuticals, Inc.A Award	VP/Chief Accounting Officer	AAward	+4,044 sh	—	—	31,197
2023-01-20	APLSApellis Pharmaceuticals, Inc.F Tax Payment	VP/Chief Accounting Officer	FTax Payment	−919 sh	$52.05	−$47.8K	27,153
2023-01-12	APLSApellis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	VP/Chief Accounting Officer	AAward	+15.1K sh	$52.66	+$796K	15,114
2023-01-12	APLSApellis Pharmaceuticals, Inc.A Award	VP/Chief Accounting Officer	AAward	+9,621 sh	—	—	28,072
2022-10-20	APLSApellis Pharmaceuticals, Inc.F Tax Payment	VP/Chief Accounting Officer	FTax Payment	−130 sh	$58.00	−$7,540	18,451
2022-08-30	APLSApellis Pharmaceuticals, Inc.F Tax Payment	VP/Chief Accounting Officer	FTax Payment	−558 sh	$58.84	−$32.8K	18,581

Recent filings

Accepted (ET)
May 144
Chopas James George0001193125-26-224627
SEC(opens sec.gov)
Jan 304
Chopas James George0001492422-26-000078
SEC(opens sec.gov)

Companies

Address

C/O APELLIS PHARMACEUTICALS, INC. 100 FIFTH AVENUE, 3RD FLOOR

WALTHAM, MA, 02451